![[1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient](/docs/US/2021-06-08/US11028090B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient
-
Application No.: US16480908Application Date: 2018-01-25
-
Publication No.: US11028090B2Publication Date: 2021-06-08
- Inventor: Kwangho Lee , Gildon Choi , Imran Ali , Joo Yun Lee , Jin Soo Lee , Whui Jung Park , Yong Tae Kim , Seung Hwan Kim , Jung Hwan Kim , Jae-Kyung Lim
- Applicant: Dong Wha Pharm. Co., Ltd. , Korea Research Institute of Chemical Technology
- Applicant Address: KR Seoul; KR Daejeon
- Assignee: Dong Wha Pharm. Co., Ltd.,Korea Research Institute of Chemical Technology
- Current Assignee: Dong Wha Pharm. Co., Ltd.,Korea Research Institute of Chemical Technology
- Current Assignee Address: KR Seoul; KR Daejeon
- Agency: Workman Nydegger
- Priority: KR10-2017-0012823 20170126
- International Application: PCT/KR2018/001128 WO 20180125
- International Announcement: WO2018/139876 WO 20180802
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P35/00 ; C07D519/00
![[1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient](/abs-image/US/2021/06/08/US11028090B2/abs.jpg.150x150.jpg)
Abstract:
Provided are a novel [1,2,4]triazolo[4,3-a]quinoxaline derivative, a method for preparing the same, and a pharmaceutical composition for preventing or treating bromodomain extra-terminal (BET) protein-related diseases including cancer and autoimmune diseases, containing the same as an active ingredient.
Public/Granted literature
Information query
